What is Vivex?
VIVEX is a pioneering entity in the field of regenerative medicine, dedicated to developing naturally sourced treatment options and solutions. The company aims to enhance clinical, surgical, and therapeutic patient care through continuous innovation. Addressing the critical need for advanced solutions for tissue damage stemming from diseases, direct injury, and trauma, VIVEX leverages the resources of the nation's oldest civilian tissue bank. By harnessing the body's inherent healing capabilities, VIVEX strives to deliver optimal patient care and provide medical professionals with cutting-edge treatment alternatives for a wide spectrum of indications.
How much funding has Vivex raised?
Vivex has raised a total of $21.9M across 3 funding rounds:
Series A
$6.6M
Private Equity
$6.3M
Debt
$9M
Series A (2015): $6.6M, investors not publicly disclosed
Private Equity (2017): $6.3M, investors not publicly disclosed
Debt (2017): $9M supported by Heritage Bank of Commerce
Key Investors in Vivex
Heritage Bank of Commerce
Heritage Bank of Commerce, established in 1994, is a business-focused financial institution based in San Jose, California, providing banking services tailored for commercial clients.
What's next for Vivex?
The recent major strategic investment in Vivex signals a pivotal moment for the company's expansion and market penetration efforts. This capital infusion is expected to accelerate the development and commercialization of its regenerative medicine technologies. With a foundation built on innovation and access to unique resources, Vivex is well-positioned to capitalize on the growing demand for advanced therapeutic solutions. Future endeavors will likely focus on scaling operations, expanding clinical applications, and forging strategic partnerships to broaden its impact in improving patient outcomes.
See full Vivex company page
